Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential Expression of Antibiotic Resistance Determinants between Men and Women by Nudel, Kathleen et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2018-06-27 
Transcriptome Analysis of Neisseria gonorrhoeae during Natural 
Infection Reveals Differential Expression of Antibiotic Resistance 
Determinants between Men and Women 
Kathleen Nudel 
Tufts University 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Bacteria Commons, Bacterial Infections and Mycoses Commons, Female Urogenital 
Diseases and Pregnancy Complications Commons, Infectious Disease Commons, Male Urogenital 
Diseases Commons, Microbiology Commons, and the Therapeutics Commons 
Repository Citation 
Nudel K, McClure R, Moreau M, Briars E, Abrams AJ, Tjaden B, Su X, Trees D, Rice PA, Massari P, Genco 
CA. (2018). Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential 
Expression of Antibiotic Resistance Determinants between Men and Women. Open Access Articles. 
https://doi.org/10.1128/mSphereDirect.00312-18. Retrieved from https://escholarship.umassmed.edu/
oapubs/3519 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Transcriptome Analysis of Neisseria gonorrhoeae during
Natural Infection Reveals Differential Expression of Antibiotic
Resistance Determinants between Men and Women
Kathleen Nudel,a Ryan McClure,b Matthew Moreau,a Emma Briars,c A. Jeanine Abrams,d Brian Tjaden,e Xiao-Hong Su,f
David Trees,d Peter A. Rice,g Paola Massari,a Caroline A. Gencoa
aDepartment of Immunology, Tufts University School of Medicine, Boston, Massachusetts, USA
bBiological Sciences Division, Paciﬁc Northwest National Laboratory, Richland, Washington, USA
cProgram in Bioinformatics, Boston University, Boston, Massachusetts, USA
dCenters for Disease Control and Prevention, Atlanta, Georgia, USA
eDepartment of Computer Science, Wellesley College, Wellesley, Massachusetts, USA
fNanjing STD Clinic, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union
Medical College, Nanjing, China
gDepartment of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts
Medical School, Worcester, Massachusetts, USA
ABSTRACT Neisseria gonorrhoeae is a bacterial pathogen responsible for the sexu-
ally transmitted infection gonorrhea. Emergence of antimicrobial resistance (AMR) of
N. gonorrhoeae worldwide has resulted in limited therapeutic choices for this infec-
tion. Men who seek treatment often have symptomatic urethritis; in contrast, gono-
coccal cervicitis in women is usually minimally symptomatic, but may progress to
pelvic inﬂammatory disease. Previously, we reported the ﬁrst analysis of gonococcal
transcriptome expression determined in secretions from women with cervical infec-
tion. Here, we deﬁned gonococcal global transcriptional responses in urethral speci-
mens from men with symptomatic urethritis and compared these with transcrip-
tional responses in specimens obtained from women with cervical infections and in
vitro-grown N. gonorrhoeae isolates. This is the ﬁrst comprehensive comparison of
gonococcal gene expression in infected men and women. RNA sequencing analysis
revealed that 9.4% of gonococcal genes showed increased expression exclusively
in men and included genes involved in host immune cell interactions, while 4.3%
showed increased expression exclusively in women and included phage-associated
genes. Infected men and women displayed comparable antibiotic-resistant genotypes
and in vitro phenotypes, but a 4-fold higher expression of the Mtr efﬂux pump-
related genes was observed in men. These results suggest that expression of AMR
genes is programed genotypically and also driven by sex-speciﬁc environments. Col-
lectively, our results indicate that distinct N. gonorrhoeae gene expression signatures
are detected during genital infection in men and women. We propose that thera-
peutic strategies could target sex-speciﬁc differences in expression of antibiotic resis-
tance genes.
IMPORTANCE Recent emergence of antimicrobial resistance of Neisseria gonorrhoeae
worldwide has resulted in limited therapeutic choices for treatment of infections
caused by this organism. We performed global transcriptomic analysis of N. gonor-
rhoeae in subjects with gonorrhea who attended a Nanjing, China, sexually transmit-
ted infection (STI) clinic, where antimicrobial resistance of N. gonorrhoeae is high
and increasing. We found that N. gonorrhoeae transcriptional responses to infection
differed in genital specimens taken from men and women, particularly antibiotic re-
sistance gene expression, which was increased in men. These sex-speciﬁc ﬁndings
may provide a new approach to guide therapeutic interventions and preventive
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measures that are also sex speciﬁc while providing additional insight to address an-
timicrobial resistance of N. gonorrhoeae.
KEYWORDS Neisseria gonorrhoeae, RNA-seq, antibiotic resistance, human mucosal
infection
Neisseria gonorrhoeae is responsible for the sexually transmitted infection (STI)gonorrhea. Rates of gonococcal infection in the United States have increased 46%
since 2011, and approximately 450,000 cases of gonorrhea were reported to the U.S.
Centers for Disease Control and Prevention in 2015. N. gonorrhoeae is the second most
common reportable bacterial STI in the United States (1). Infection with N. gonorrhoeae
also contributes signiﬁcantly to global STI morbidity and is responsible for 78 million
cases each year (2). For the past 8 decades, gonorrhea has been treated successfully
with antibiotics, despite patterns of resistance, but over the last several years,
multidrug-resistant and untreatable strains have begun to emerge worldwide. Resistant
strains include isolates from both Eastern and Western Europe (3, 4), Asia (5–7), and
recently the United States (8–10). This rise in antibiotic-resistant strains may be linked,
in part, to an increase in availability of over-the-counter antibiotics, particularly in many
parts of Asia. New strategies for combating this disease are necessary, as evidenced
by increased efforts to develop gonococcal vaccines (11, 12) and new drug regi-
mens (7, 13, 14).
In humans, the only natural host for N. gonorrhoeae, symptomatic responses to
infection are unique to men and women. While most infected men remain asymptom-
atic (15), those who develop symptoms often show robust inﬂammation characterized
by purulent urethral discharge accompanied by large numbers of polymorphonuclear
leukocytes (PMNs). In women, gonococcal infections are asymptomatic 50 to 80% of
the time (16) or are accompanied by nonspeciﬁc symptoms such as vaginal discharge
(17). The presence of cervical mucus or microscopic PMN counts of 10 seen micro-
scopically on an oil immersion ﬁeld does not correlate well with gonococcal infection
in the absence of coinfecting agents (18). Manifestations of gonococcal infection may
be driven by environmental factors speciﬁcally associated with the genital tracts of men
and women: these may include bioﬁlm formation (19, 20); the inﬂuence of the micro-
biome, particularly in women (21–25); and both direct and indirect molecular interac-
tions between gonococci and speciﬁc host cells from men or women (26–30).
Gonococcal pathogenesis and host immune responses have been studied princi-
pally in vitro and in animal models (31), both of which may not faithfully replicate
differences in infection between men and women. Historically, the only human model
of gonococcal infection is based on genital experimental challenge of male volunteers,
which has provided valuable information on gonococcal virulence factors, but is limited
by the duration of the experimental infection and is not applicable to women (32, 33).
A better understanding of gonococcal pathogenesis during natural mucosal infection,
which is less well studied, is critical to implement biological strategies to treat and
prevent infection. Previous work from our group using a gene-speciﬁc microarray and
reverse transcription-quantitative PCR (qRT-PCR) analysis demonstrated that at least 20
gonococcal iron-regulated genes were expressed during human mucosal infection in
men and women (34, 35). Recently, we also examined the complete N. gonorrhoeae
transcriptome using cervicovaginal lavage specimens of infected women attending an
STI clinic in China where antibiotic-resistant N. gonorrhoeae is prevalent (36, 37). We
reported that a large portion of the gonococcal genome is expressed (65% of protein-
coding genes) and regulated during infection (305 genes regulated compared to in
vitro growth) (38). In the present study, we examined gonococcal transcriptomes from
men attending the same clinic and compared bacterial gene expression and regulation
in infected men with expression and regulation in infected women. The resulting data
revealed sex-speciﬁc adaptation of genes involved in host-pathogen interactions and
phage and antibiotic resistance.
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RESULTS
Description of subjects. The male cohort comprised six male subjects (average age,
34 years) attending the Nanjing (China) Sexually Transmitted Disease (STD) Clinic, who
presented with urethral discharge and/or dysuria and were diagnosed with N. gonor-
rhoeae infection (Table 1). Four men were coinfected with Chlamydia trachomatis
and/or Mycoplasma genitalium, three had a history of prior gonococcal infection, and
three had self-administered antibiotics prior to their clinic visit (Table 1). In contrast,
none of the seven enrolled women had a history of gonococcal infection or had taken
antibiotics prior to their clinic visit (see Table S1 in the supplemental material). Two
gonococcal strains were isolated from a man and a woman who comprised a single
dyad (subjects M-4 and F-6, respectively).
Gonococcal gene expression in the human genital tract. RNA was extracted from
male urethral or cervicovaginal lavage specimens, and individual cDNA reads were
aligned to N. gonorrhoeae strain FA1090 using Rockhopper (39). Total gene expression
was reported in reads per kilobase per million (RPKM). On average, 8.1% of the total
RNA from male urethral specimens aligned to the N. gonorrhoeae FA1090 genome and
42.5% to the human genome; 4.3% of total RNA from cervicovaginal lavages aligned to
FA1090 and 45% to the human genome.
Expression of 1,725 gonococcal genes (approximately 65% of the gonococcal ge-
nome) was detected in male urethral specimens. High expression of a core set of genes
that encoded oxidative stress products (e.g., peroxiredoxin/glutaredoxin), housekeep-
ing genes (e.g., the gene coding for elongation factor Tu), outer membrane protein
genes (e.g., genes coding for Rmp [Omp3] and porin P.IB), and hypothetical protein
genes were identiﬁed across male specimens (see Table S3 in Data Set S1 in the
supplemental material). A more detailed analysis of the top 200 gonococcal genes
(approximately 10% of total genome) that were expressed in all six male urethral
secretions (in aggregate) was carried out by determining the ratio of gene enrichment
and segregation into broad categories. Despite some variability in RPKM values among
subjects, signiﬁcantly enriched categories included genes coding for pilin and oxidative
stress and regulatory proteins (Fig. 1), which reﬂected a common pattern of high gene
expression during natural infection.
Gonococcal gene regulation in the male genital tract. Our earlier studies had
demonstrated that approximately 17% of gonococcal genes were regulated in vivo
during cervical infection in women (38). Gonococcal gene expression in the male
genital tract was compared to expression of matched infecting strains grown in vitro by
analysis of transcriptome sequencing (RNA-seq) data sets for individual strains and for
the composite data sets. Genes that displayed a signiﬁcant difference in expression
under in vivo versus in vitro conditions were selected for further analysis based on the
following criteria: a 2-fold difference in RPKM value, a q (false-discovery rate) value of
0.05, and expression greater than 10 RPKM under at least one condition (see
Table S4 in Data Set S1). The majority of genes were expressed similarly in vivo and in
vitro, but approximately 4.2% of the total number of genes detected (79 genes)
TABLE 1 Characteristics of male subjects with gonococcal urethritis
Subject
Age
(yr)
No. of
days with
symptoms
Other STI
microbe(s)
Urethral
PMN scorea
Prior
gonococcal
infection
ABX in last
30 daysb
M-1 27 4 C. trachomatis  Yes Yes
M-2 37 21 None  No No
M-3 46 3 None  Yes No
M-4 28 3 M. genitalium  No Yes
M-5 34 15 M. genitalium,
C. trachomatis
 Yes Yes
M-6 32 1 C. trachomatis  No No
aNumber of PMNs per oil immersion ﬁeld indicated: , 5 to 9; , 10.
bSelf-administered antibiotics (ABX) prior to diagnosis in the STD clinic.
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revealed increased expression in vivo compared to that observed in vitro; expression of
5.2% (99 genes) was decreased in vivo compared to that observed in vitro (Fig. 2A).
Regulation of gonococcal gene expression was then examined by functional en-
richment analysis (Fig. 2B). Genes involved in iron and oxidative stress pathways and
genes encoding hypothetical proteins were among those signiﬁcantly enriched and
were more highly expressed in vivo than in vitro. For example, expression of certain
iron-scavenging genes (e.g., fbpA, tbpA, and tbpB) and of the fur-controlled regulator
arsR was signiﬁcantly higher in vivo than in vitro, although variance in arsR in vivo
expression was large (Fig. 2C). This observation suggests that the male genital tract is
iron depleted (similar to the female genital tract [38]). Genes involved in energy
metabolism were also signiﬁcantly enriched but had decreased expression in vivo
(Fig. 2B). Among the downregulated energy metabolism genes was the nuoA–N operon
(NGO1737–1751) (40), involved in aerobic respiration; its overall decreased expression
in vivo may suggest a mechanism for bacterial survival in an anaerobic environment
(41).
Among the enriched oxidative stress genes increased in vivo, we observed a
signiﬁcant increase in a glutaredoxin family protein gene (NGO0031), the thioredoxin I
(trx1) gene (NGO0652), and msrAB (NGO2059) (Fig. 2D). The family of glutaredoxin
proteins function as glutathione-dependent reductases (42); msrAB plays a role in
reducing oxidized methionines to reactive peptides (43) and trx1 has been shown to
respond to oxidation and is under control of the Fur regulon (44, 45). While expression
of the well-studied OxyR regulon (oxyR, prx, kat, and gor) was not signiﬁcantly different
in in vivo samples compared to cultures grown in vitro, we observed decreased
expression of the OxyR repressor in vivo, with increased expression of genes within the
OxyR regulon (prx, kat, and gor). This notable trend further suggests that the gono-
coccus is exposed to reactive oxygen species during mucosal infection in men (Fig. 2D)
(46, 47).
Several gonococcal noncoding RNAs were also regulated during infection in men.
These included 4 rRNAs and 29 tRNAs, which were expressed at higher levels during
infection compared to growth in vitro, except for NGO t31, an arginine tRNA that was
expressed more highly during in vitro growth (see Table S5 in Data Set S1). Putative
small RNAs (sRNAs: deﬁned as expression representing an intergenic region of the
complementary strand of a known open reading frame [ORF] and 30 to 250 nucleotides
in length) were also regulated during infection; 29 sRNAs were increased in vivo
FIG 1 Categorization of the top 200 N. gonorrhoeae genes expressed during natural infection in men.
Expression of gonococcal genes in 6 infected men was averaged, and the top 200 genes were
categorized based on characteristics indicated for N. gonorrhoeae strain FA1090 available in NCBI.
Categories are shown on the y axis, and the ratio of enrichment (% of genes of a given functional
category in RNA-seq data set/% of genes assigned to that functional category in whole gonococcal
genome) is shown on the x axis. For clarity, ribosomal protein, tRNA, and rRNA genes were removed.
Asterisks indicate that enrichment was signiﬁcant (P  0.05) by Fisher’s exact test.
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compared to in vitro, and 21 sRNAs were decreased in vivo (see Table S6 in Data Set S1).
Among these sRNAs, several have been described previously (48, 49).
Comparison of gonococcal gene signatures in the male and female genital
tracts. Building on gonococcal transcriptome data in infected men and women, we
examined whether site-speciﬁc, environmental conditions inﬂuenced expression of
gonococcal genes during infection. A comparative transcriptome analysis was carried
out using the 6 urethral and 7 cervicovaginal specimens. We performed principal-
component analysis (PCA) to assess whether global in vivo gene expression revealed
transcriptional signatures speciﬁc for infections in men or women (Fig. 3A). PCA showed
a clear distinction between gonococcal genes expressed in specimens from men
and women, with high variance among the 7 specimens from women compared to
low variance in men, as evidenced by tight clustering when the ﬁrst two principal
components were plotted against each other (Fig. 3A). Gene expression analysis of the
composite data sets was also performed; parameters set for deﬁning differential gene
regulation were a 2-fold change in RPKM, a q value of 0.05, and expression greater
than 10 RPKM under at least one condition (see Table S5 in Data Set S1). Of 1,879 genes
expressed, 176 (9.4%) were increased in men compared to women and 80 (4.3%) were
decreased in men, indicating that nearly 14% of gonococcal genes were differentially
FIG 2 Comparison of N. gonorrhoeae gene expression in infected men in vivo and isolates grown in vitro. (A) Composite gene expression levels in urethral
specimens (n  6) on the y axis plotted against composite expression of corresponding gonococcal isolates (n  6) grown in vitro (x axis). Data are shown as
log10 expression (RPKM) levels. The genes indicated in light blue had q values of 0.05 and 2-fold changes in vivo (versus in vitro). (B) Functional enrichment
of genes with statistically signiﬁcant changes in expression under in vivo and in vitro conditions. Genes were differentially expressed if the q value was 0.05
and the fold change was 2. Black bars represent functional enrichment of genes with increased expression in vivo. Gray bars represent functional enrichment
of genes with decreased expression in vivo. Categories are shown on the y axis, and the ratio of enrichment (% of genes of a given functional category in
RNA-seq data set/% of genes assigned to that functional category in whole gonococcal genome) is shown on the x axis. Ribosomal protein, tRNA, and rRNA
genes were removed for clarity. *, signiﬁcant enrichment among genes increased in vivo (versus in vitro), and #, signiﬁcant enrichment among genes decreased
in vivo, with P  0.05, by Fisher’s exact test. (C and D) Expression levels of iron genes (C) and oxidative stress genes (D) under in vivo and in vitro conditions.
(Six male specimens [in vivo] and the corresponding 6 isolates [in vitro] are shown in the same color in adjacent columns.) *, q  0.05.
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regulated during gonococcal infection in the male and female genital tracts (see
Table S7 in Data Set S1).
A functional enrichment analysis of gene categories performed on male and female
specimens revealed that phage-associated genes were signiﬁcantly enriched in female
specimens (Fig. 3B). While female specimens had higher expression of a broad range of
phage types (e.g., double-stranded and ﬁlamentous single-stranded phages), male
specimens had higher expression in the subset of double-stranded DNA prophages
(see Fig. S1A in the supplemental material) (50). Other highly expressed categories
enriched in male specimens included genes that encoded hypothetical proteins and
proteins involved in host interactions (Fig. 3B). Iron and oxidative stress genes that were
differentially expressed in male and female specimens included the ferredoxin gene
FIG 3 Comparison of N. gonorrhoeae gene expression during infection in men and women in vivo. (A)
Variance in global expression in each specimen from men and women. The ﬁrst principal component
(PC1 [x axis]) had a variance of ~26%, and the second principal component (PC2 [y axis]) had a variance
of ~14%. (B) Functional enrichment of genes with signiﬁcant changes in expression levels in men and
women. Genes were differentially expressed if the q value was 0.05 and the fold change was 2. Blue
bars represent genes with increased expression in vivo in men compared to women. Red bars represent
genes with increased expression in vivo in women compared to men. *, signiﬁcant enrichment among
genes increased in vivo in men; #, signiﬁcant enrichment among genes increased in vivo in women.
Nudel et al.
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(NGO1859), a TonB receptor protein gene (NGO1205), and fetA (NGO2093). (fetA is
regulated by MpeR and induced under low-iron conditions [51].) These genes all
manifested increased expression in women (Fig. S1B). In contrast, expression of the
oxidative stress gene bfrB was increased in male specimens; other oxidative stress
genes were similarly expressed in both men and women (Fig. S1C), suggesting that
exposure to oxidative stress occurs in both the male and female genital tracts.
Regulation of several gonococcal sRNAs was also observed. A signiﬁcant change in
expression of 119 sRNAs was observed in specimens obtained from men and women:
28 were expressed at higher levels in male specimens and 91 in female specimens.
Previously identiﬁed sRNAs showing regulation based on sex included smRNA4,
smRNA5, and smRNA8 (49), fnrS (a small RNA induced under anaerobic conditions
[44]), and the iron-repressed sRNA encoding NrrF (52) (see Table S6 in Data Set S1). In
addition, 45 tRNAs showed differential regulation, with all being more highly expressed
in female patients than in male patients (see Table S5 in Data Set S1).
Expression of antimicrobial resistance genes. Gonococcal antimicrobial resis-
tance (AMR) is a growing concern and is common in strains from the eastern regions
of the world, including China. We examined phenotypic and genotypic AMR patterns
from our cohort and found that all the isolates exhibited resistance to penicillin,
tetracycline, and ciproﬂoxacin, with one isolate showing resistance to azithromycin
(Table 2). One isolate also showed reduced susceptibility to ceftriaxone. Strains isolated
from women exhibited similar antimicrobial susceptibility patterns (Table 2). These
results were similar to AMR patterns of male urethritis strains reported earlier (2011 to
2012) from the Nanjing STD Clinic (53).
Whole-genome DNA sequencing (WGS) was performed on all available strains (6
male and 6 female) to deﬁne strain relatedness and genotypic determinants of antibi-
otic resistance. A single-nucleotide polymorphism (SNP) distance tree was constructed
that used SNP distances (differences) that ranged between 81 and 3,913 separating the
genomes (see Fig. S2 in the supplemental material). The male and female dyad (M-4
and F-6) yielded genomic sequences that were separated by only 81 SNPs. Strain
NCCP11945 isolated from a subject with gonococcal disease in South Korea (average
SNP distance of 2,828 SNPs compared to strain FA1090) shared considerable homology
with the isolates obtained from our cohort compared to the commonly used laboratory
strain, FA1090 (average distance of 4,212 compared to FA1090).
Genomic analyses based on publicly available, curated, antibiotic resistance data-
bases (CARD and GC-MLST) identiﬁed multiple AMR genes (Table 2) and SNP-level
variants that likely contributed to phenotypic resistance. All gonococcal strains exhib-
ited SNP mutations in gyrA and/or parC (which confer resistance to ﬂuoroquinolones),
SNP mutations in penA, ponA, porB, and pilQ (-lactam resistance), and SNP mutations
in rpsJ (tetracycline resistance) (54). Only one isolate (M-5) carried plasmid-based
resistance genes (tem-1 and tetM). Interestingly, among the male subjects, M-3 was the
only isolate to exhibit azithromycin resistance and a corresponding mutation in the 23S
rRNA gene (55). Three isolates had an adenosine deletion in the promoter region of
mtrR, the repressor of the mtrCDE efﬂux pump, a system that exports bactericidal
host-derived compounds and hydrophobic antibiotics (-lactams and macrolides) from
the bacterial cell (56–58). Isolates from women exhibited similar genomic patterns of
resistance: by and large, the same mutations identiﬁed in the male isolates were also
present in the female isolates (Table 2). Among 6 SNPs associated with -lactam
resistance in the dyad isolates (subjects M-4 and F-6, who were infected by the same
strain), 5 SNPs were shared in the dyad isolates. Two SNPs in gyrA were shared (S91F
and D95N), and a Ser SNP in parC [parC(S87I)] was detected only in the male isolate.
Finally, while several SNP mutations coincided with phenotypic resistance to azithro-
mycin, ciproﬂoxacin, and penicillin (Table 2), the single isolate with decreased sensi-
tivity to ceftriaxone (M-3) did not possess the mosaic penA XXXIV allele (59) or any
additional curated mutations that distinguished it from the phenotypically sensitive
strains (Table 2) (59, 60).
Gonococcal Gene Expression in Men and Women
May/June 2018 Volume 3 Issue 3 e00312-18 msphere.asm.org 7
 o
n
 August 16, 2018 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
Expression levels of genes associated with antibiotic resistance in men were also
compared to expression of corresponding genes in vitro (Fig. 4A and B). Expression of
the pilQ gene, associated with antibiotic permeability (14), was signiﬁcantly decreased
by 1.78-fold in vivo compared to in vitro (Fig. 4A). The MisRS two-component regulatory
system is important for resistance to host-derived antimicrobial peptides and antibiot-
ics (61), and though not statistically signiﬁcant, misR had 2.08-fold higher expression in
vivo compared to in vitro, supporting its important role in vivo. The expression of the
Mtr efﬂux pump was also closely examined; expression of mtrA, which can inﬂuence
TABLE 2 Phenotypic resistance and AMR genes identiﬁed in male and female N. gonorrhoeae isolates (n  13) by WGSa
Subject
Efﬂux pump
mutation:
lipophilic
antibiotics
-Lactams Macrolides Fluoroquinolones Tetracyclines Amino-
cyclotols:
SPT MIC
(g/ml)d,e
CRO MIC
(g/ml)b
PEN MIC
(g/ml)c Mutation
AZM MIC
(g/ml)b Mutation
CIP MIC
(g/ml)c Mutation
TET MIC
(g/ml)b Mutation
M-1 0.06 2 (R) penA(F504L A501V
P551S)
0.25 4 (R) gyrA(S91F) 2 (R) rpsJ(V57M) 16
porB(A121D G120K)
ponA(L421P)
pilQ(S341N)
M-2f Adenosine deletion
in mtrR promoter
0.032 0.25 penA(F504L A501V) 0.125 4 (R) gyrA(S91F) 24 (R) rpsJ(V57M) 2
porB(G120K)
ponA(L421P)
pilQ(N648S)
M-3 Adenosine deletion
in mtrR promoter
0.125 (DS) 2 (R) penA(F504L A501T) 8 (R) 23S rRNA
(C2599T)
4 (R) gyrA(S91F) 2 (R) rpsJ(V57M) 16
porB(A121D G120K)
ponA(L421P)
pilQ(S341N)
M-4g Adenosine deletion
in mtrR promoter
0.06 1 (I) penA(F504L A501T) 0.5 (I) 4 (R) gyrA(S91F D95N) 2 (R) rpsJ(V57M) 16
porB(A121D G120K) parC(S87I)
ponA(L421P)
pilQ(S341N)
M-5 0.06 8 (R) TEM-1(plasmid) 0.125 4 (R) gyrA(S91F) 16 (R) rpsJ(V57M) 16
porB(A121D G120K)
ponA(L421P) tetM(plasmid)
pilQ(S341N)
M-6 Adenosine deletion
in mtrR promoter
0.06 4 (R) penA(F504L A501V) 0.5 (I) 4 (R) gyrA(S91F) 4 (R) rpsJ(V57M) 16
porB(A121D G120K)
ponA(L421P)
pilQ(S341N)
F-1 Adenosine deletion
in mtrR promoter
0.03 4 (R) penA(F504L P551S
A501V)
0.25 8 (R) gyrA(S91F
D95N)
2 (R) rpsJ(V57M) 16
porB(A121D G120K) parC(S87R)
ponA(L421P)
pilQ(N648S)
F-2 Adenosine deletion
in mtrR promoter
0.015 8 (R) penA(F504L A501V
D345A)
0.5 (I) 8 (R) gyrA(S91F) 16 (R) rpsJ(V57M) 16
porB(A121D G120K) parC(S87R)
F-3 Adenosine deletion
in mtrR promoter
0.06 2 (R) penA(F504L A501V) 1 (R) 8 (R) gyrA(S91F
D95N)
16 (R) rpsJ(V57M) 16
porB(G120K)
ponA(L421P)
pilQ(S341N)
F-5 Adenosine deletion
in mtrR promoter
0.008 0.125 (I) penA(F504L P551S
A501V)
0.015 2 (R) gyrA(S91F
D95G)
0.5 (I) rpsJ(V57M) 16
porB(A121D G120K)
ponA(L421P)
pilQ(S341N)
F-6g Adenosine deletion
in mtrR promoter
0.06 1 (I) penA(F504L A501T) 1 (R) 4 (R) gyrA(S91F
D95N)
2 (R) rpsJ(V57M) 32
porB(A121D G120K)
ponA(L421P)
pilQ(S341N)
F-7 Adenosine deletion
in mtrR promoter
0.015 2 (R) penA(F504L) 64 (R) 23S rRNA
(A2143G)
4 (R) gyrA(S91F D95A) 16 (R) rpsJ(V57M) 32
porB(A121D G120K) parC(S87R)
ponA(L421P)
pilQ(S341N)
aCRO, ceftriaxone; PEN, penicillin; AZM, azithromycin; CIP, ciproﬂoxacin; TET, tetracycline; SPT, spectinomycin; S, susceptible; DS, decreased susceptibility; I, intermediate
resistance; R, resistant.
bS  0.25 g/ml.
cS  0.06 g/ml.
dS  32 g/ml.
eNo mutation was found to confer resistance to aminocyclotols.
fIsolate did not grow in agar dilution media, and MICs were determined by Etest on chocolate agar.
gMale and female partners in the dyad (M-4 and F-6).
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expression of mtrCDE (62), was signiﬁcantly decreased by 2.75-fold in vivo (Fig. 4B).
Gonococcal strains from male urethral specimens (M-2, M-3, M-4, and M-6) contained
an adenosine deletion in the mtrR promoter that was accompanied by the lowest
expression of mtrR and highest expression of mtrCDE and mtrF, conﬁrming that the
adenosine deletion directly affects expression of the Mtr locus (63) in vivo. Expression
ofmpeR was also investigated, as it has been shown to regulate the Mtr locus; however,
expression was below 10 RPKM in all in vitro and in vivo samples.
Transcriptomes from male urethral specimens were also compared with female
cervicovaginal lavage specimens to determine if expression of AMR genes was inﬂu-
enced by sex (Fig. 4C). Because of the adenosine deletion in the mtrR promoter in 4/6
males (described above) and all female isolates (Table 2), expression of mtrR was low in
both groups and resulted in signiﬁcantly higher expression of mtrCDE and mtrF in men,
as predicted (63), but not in women. Even within the dyad, where both M-4 and F-6
contained the adenosine deletion in the mtrR promoter, M-4 had approximately 2
higher expression levels of mtrCDE than F-6. Interestingly, the expression of mtrA, an
activator of mtrCDE (62), was signiﬁcantly higher during infection in women compared
to men, despite lower expression of mtrCDE in women (Fig. 4C). The farR gene, which
negatively controls expression of the farAB operon by directly binding to the farAB
promoter (64) to prevent excess expression of gonococcal efﬂux pumps, also showed
FIG 4 Expression of gonococcal antibiotic resistance genes. Expression levels of antibiotic resistance genes (A) and the Mtr efﬂux pump (B) in the male genital
tract (in vivo) and the corresponding strain in CDM (in vitro); genes are identiﬁed on the x axis. (Six male specimens [in vivo] and the corresponding 6 isolates
[in vitro] are shown in the same color.) *, q  0.05. (C) Expression levels of antibiotic resistance genes from the male genital tract (blue) or the female genital
tract (red). *, higher gene expression in men; #, higher gene expression in women (q  0.05). Red and blue X’s indicate the male (M-4) and female (F-6)
counterparts of the dyad.
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signiﬁcantly higher expression in cervicovaginal lavages. Collectively these results
suggest that, although strains isolated from infected men and women exhibit compa-
rable AMR genotypes and in vitro phenotypes, expression of AMR genes is different
during infection in the male and female genital tracts.
DISCUSSION
N. gonorrhoeae infects the male and female genital tracts, two very distinct envi-
ronments in humans. As there is little doubt about the intrinsic tissue, cellular, and
molecular differences that deﬁne these host environments, it is reasonable to assume
that the gonococcus will adapt to these environmental differences during infection
(65). Building on our previous results on the gonococcal transcriptome proﬁle during
infection in women (37), we extended our analysis to specimens from infected men. In
the present study, we not only report a distinct gonococcal transcriptome proﬁle in vivo
compared to in vitro in infected men, but also, for the ﬁrst time, describe a comparison
of N. gonorrhoeae gene expression during infection in the male and female genital
tracts. Our results also demonstrate distinct gonococcal gene expression signatures in
men and women, consistent with the intrinsically different makeups and natures of the
two sites of infection. Furthermore, our approach based on both whole-genome and
RNA sequencing enabled us to evaluate expression of antibiotic resistance determi-
nants during infection in both the male and female genital tracts.
Currently, the only human model of gonococcal infection is experimental urethral
challenge of male volunteers. Those studies have examined gonococcal virulence
factors and have provided valuable information on opacity proteins and genes involved
in iron acquisition, structural modiﬁcation of lipooligosaccharides, and a variety of other
established virulence factors (32, 66, 67) but are limited by the short duration of
experimental infection. The small number of infecting strains used experimentally in
men (mostly laboratory-adapted strains FA1090 and MS11mkC [32]) have precluded an
in-depth understanding of the range of adaptions employed during gonococcal infec-
tions generally. Using a panel of N. gonorrhoeae strains isolated from infected subjects,
we compared the gonococcal in vivo transcriptome expressed during infection of
the male genital tract to that of the corresponding infecting strains grown in vitro. Our
results revealed increased expression of genes involved in oxidative stress and iron
scavenging in vivo, accompanied by decreased expression of genes involved in
metabolism-associated categories (i.e., energy and amino acid metabolism). In partic-
ular, we observed that gonococci expressed high levels of trx1,msrAB, and glutaredoxin
genes during infection in male subjects, in agreement with the large PMN inﬂux that
occurs during infection in symptomatic men. Our results also demonstrated increased
expression of iron-regulated genes (tbpAB [66]), indicating that the male genital tract is
an iron-depleted environment. We observed lower expression of genes involved in
gonococcal aerobic energy metabolism processes and higher expression of oxidative
stress response genes in urethral specimens compared to that of the corresponding
infecting strains grown in vitro. It is established that the genital tract is anaerobic or
microaerobic (68, 69). Thus, we would expect that a comparison of RNA-seq data sets
from urethral and cervicovaginal lavage specimens to RNA-seq data sets from in vitro
growth conditions would identify differential regulation of gonococcal genes utilized
for aerobic energy production. However, the presence of neutrophils, especially in male
subjects during infection, likely requires a corresponding N. gonorrhoeae oxidative
defense response. Such immune cells are obviously absent under our in vitro condi-
tions, and thus these oxidative stress pathways are expressed at lower levels. While
we recognize that in vitro culture conditions differ compared to the conditions in
the human genital tract beyond metabolite content, this study provides a gene-
speciﬁc view of the response of N. gonorrheoae to infection and leads to a number
of hypotheses regarding infection mechanisms that can be explored in more detail
in future studies.
While we identiﬁed both expected and novel differences in gonococcal gene
expression during human infection compared to in vitro growth, the most revealing
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aspect of our study was the differential gonococcal expression proﬁles observed in
men and women. Our results showed that nearly 14% of gonococcal genes that
were expressed in human infection were differentially expressed in men and women.
Principal-component analysis demonstrated that gonococcal expression in men and
women separated into distinct gene expression signatures, with high variance among
the 7 female specimens and low variance among the 6 male specimens. We acknowl-
edge that high variance could be due to the small sample size, but it may also be due
to other female-speciﬁc environmental factors that could alter gonococcal gene ex-
pression, such as menstrual cycle or the microbiome, which exhibits diversity among
individuals (70). We also observed differences in the presence and type of coinfecting
organisms in infected men and women. Several male subjects had a coinfection of
Chlamydia trachomatis or Mycobacterium genitalium, and while some female subjects
were also infected with these pathogens, several females additionally carried Urea-
plasma urealyticum. In addition, 3/7 of the female subjects had bacterial vaginosis (BV),
suggesting differences in their natural microﬂora in combination with these coinfec-
tions. We hypothesize that changes in the microﬂora and the presence of coinfecting
organisms have a direct effect on the transcriptomic response of N. gonorrhoeae, as
does the variable host response during coinfection compared to infection with N. gon-
orrhoeae alone. Both of these factors most likely impact the overall differences ob-
served between samples of the same gender as well as differences observed in the
gonococcal transcriptomic response during infection in men and women. When
genomic DNA sequence analysis was also considered, there was no clustering among
strains derived from men or women (except for strains in the single dyad), which
strongly suggests that the observed differences in transcriptomic signatures were
driven by exposure of gonococci, generally, to the male or the female genital tract and
not by strain relatedness. Furthermore, this is also supported in the single dyad by
differences in gene expression manifested by the same strain in each partner, which
reﬂected changes in gene expression that were seen overall in the other men and
women. In addition to the small sample size, it is important to also consider other
limitations of the study when interpreting sex-speciﬁc and growth-speciﬁc aspects of
N. gonorrhoeae infection. Due to the design of the study, men are recruited because
they enter the clinic with a symptomatic response: thus, men may have a similar stage
of infection and gonococcal growth stage. This is in contrast to the matched females,
who are partners of the recruited men and who were at various stages of infection and
therefore gonococcal growth.
Among the most relevant gonococcal transcriptome differences that emerged in
male and female specimens were those in genes encoding antimicrobial resistance
determinants. The rise of antibiotic resistance in N. gonorrhoeae is now a global concern
(71). Patterns of resistance vary among countries because of population mobility and
geographically localized increases in antimicrobial resistance—such as those observed
in China (72); these patterns are predictive of future resistance patterns in countries that
currently have lower levels of resistance, such as the United States (73, 74). Whole-
genome DNA sequencing (WGS) of the gonococcal strains isolated from our male and
female cohort revealed similarity of genetic determinants of resistance to strains
isolated in the United States (59). In all strains, regardless of the origin of the specimens
(men or women), the presence of an adenosine deletion in the mtrR promoter (also
detected by WGS) correlated with increased expression of the Mtr regulon. Neverthe-
less, strains isolated from men showed a signiﬁcantly higher expression of mtrCDE and
mtrF than those from women. While a direct explanation for these results remains
speculative, it is possible that the higher expression ofmtrCDE observed in men may be
due to the readily accessible antibiotics in China; approximately half of the male
subjects (but none of the female subjects) in this study had self-administered antibi-
otics prior to seeking care at the STD clinic. Future studies including a larger cohort may
help resolve these differences. An additional explanation for gender-speciﬁc differences
is that bioﬁlm formation in the female genital tract (and apparent lack of it in the male
genital tract) is a contributing factor (19, 20). Bioﬁlms can provide protection against
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harsh environments, and their absence in the male genital tract may lead to increased
expression of antibiotic-resistant efﬂux pumps as a defense mechanism (75, 76).
N. gonorrhoeae contains phage DNA inserted in the genome: ﬁve regions compris-
ing double-stranded DNA (dsDNA) lysogenic phage genomes (50) and four additional
regions comprising ﬁlamentous phages (77). The role of phage genes in N. gonorrhoeae
infection has not been studied extensively. Previous work from our group has identiﬁed
a phage gene, npr, involved in invasion of female epithelial cells in vitro, which
correlates with disease progression in a female mouse model of gonococcal infection
(78). Our ﬁnding that expression of phage genes was increased in female subjects may
also relate to the formation of bioﬁlms in the female genital tract (20). We propose that
bioﬁlm formation may facilitate DNA exchange via phages among bacteria, thus
contributing to differences in infections of men and women. Additional transcriptional
patterns that differentiated organisms obtained during infection in men and women
included genes encoding tRNAs with higher expression observed in women compared
to men. However, apparent expression of tRNAs may be partially affected by reads
aligning to additional microbes present in the genital tract: tRNA genes are highly
conserved across species, and the women in the study may have a larger population of
microbial organisms. Six of seven gonococcus-infected women reported in this study
had BV and/or other bacterial genital infections. Some studies have suggested a role for
tRNAs in bacterial infection (79, 80), and it is possible that differences observed in men
and women also correlate with the enhanced microbial environment in women. Small
RNA expression in vivo was also different; NrrF and FnrS (an sRNA induced under
anaerobic conditions) were expressed at higher levels in women than in men.
Collectively, our results provide the ﬁrst global view of gonococcal gene expression
during infection in humans and deﬁne gene signatures speciﬁc to infections in men
and women. We report important differences related to antibiotic resistance and
gonococcal pathogenesis that can be extrapolated to improve understanding of gono-
coccal disease outcomes and potential treatments. Our analysis also highlights short-
falls of studying bacterial infections using in vitro models and systems. It is critical that
studies designed to identify targeted therapies for gonococcal infections consider
sex-speciﬁc differences in gene expression proﬁles that may impact treatment out-
comes. Furthermore, addressing how expression of antimicrobial resistance genes are
driven by environmental cues in the male and female genital tracts has important
implications for the use of targeted antibiotics.
MATERIALS AND METHODS
Ethics statement. All subjects provided written informed consent in accordance with requirements
by Institutional Review Boards from Tufts University, Boston, MA (protocol no. 11710), the University of
Massachusetts Medical School, Worcester, MA, and Boston University School of Medicine, Boston, MA,
and the Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical
College, Nanjing, China.
Identiﬁcation of subjects and characterization of urethral infections. Urethral swab specimens
were collected from six men attending the Nanjing Sexually Transmitted Disease (STD) Clinic, chosen at
random, who were participants in a study of gonococcal transmission (81). Male subjects presented with
symptoms and signs of urethritis (dysuria and/or urethral discharge). Gram stains of urethral exudates
showed PMNs and Gram-negative intracellular diplococci, criteria that are highly speciﬁc (99%) for
gonococcal infection (82). Urethral swab specimens from men with urethritis were also inoculated onto
Thayer-Martin medium (DL Biotech, China) and cultured in candle jars at 36°C. Gonococcal isolates were
identiﬁed by colonial morphology, Gram stain, and oxidase testing. Urethral swab specimens were also
tested for Chlamydia trachomatis andMycoplasma genitalium by PCR (83, 84) and Ureaplasma urealyticum
and Mycoplasma hominis by culture using the Mycoplasma IST2 test (BioMérieux, France).
Collection of cervicovaginal lavage specimens (n  4) was described previously (38), and three
additional specimens were obtained for the present study (total n  7). PCR testing using primers
directed against the gonococcal porA pseudogene (85) had previously identiﬁed N. gonorrhoeae infection
in one woman (F-4) whose cervical culture was negative. Women reported that they were monogamous
(3/7 were married), having been the sole sex partner of a man with gonococcal urethritis. One woman
(F-6) and one man (M-4) were members of a single dyad.
Antimicrobial testing of N. gonorrhoeae. N. gonorrhoeae strains from urethral swab and cervico-
vaginal lavage specimens were identiﬁed and processed as previously described (38). Antimicrobial
sensitivity testing of N. gonorrhoeae isolates was determined for penicillin, tetracycline, spectinomycin,
azithromycin, ceftriaxone, ceﬁxime, and ciproﬂoxacin at the Nanjing STD Clinic. Mean inhibitory con-
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centrations (MICs) were determined by the agar dilution method, and current Clinical and Laboratory
Standards Institute cutoffs were used, except for azithromycin, in which we followed the European
Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org) (86). A single isolate (from
M-2) that did not grow in agar dilution media or GC agar had MICs determined on chocolate agar by
Etest: thus, MIC values may be one dilution lower due to enriched agar (87).
RNA isolation. Total RNA was isolated from urethral swab and cervicovaginal lavage specimens
using TRIzol (Invitrogen) as described previously (38). Brieﬂy, specimens were washed twice with 70%
ethanol and treated with Turbo DNase (Ambion), the RiboMinus kit (Invitrogen) (to deplete eukaryotic
rRNA), and the Microbe Express kit (Ambion) (to deplete bacterial rRNA) using diethylpyrocarbonate
(DEPC)-treated EDTA-free water. Gonococcal isolates that corresponded to each specimen were grown
overnight on chocolate agar plates at 37°C in 5% CO2 prior to inoculation in chemically deﬁned medium
(CDM) containing ferric nitrate (100 M). Liquid cultures were inoculated at an optical density at 600 nm
(OD600) of 0.1, harvested after 3 h, and pelleted, and RNA was extracted as described above.
RNA sequencing and analysis. RNA sequencing was performed as previously described (38). cDNA
libraries were prepared with TruSeq RNA preparation kit and sequenced on an Illumina HiSeq 2500
instrument using high-output V3 chemistry in single-read 100 formats. Analysis of RNA-seq data was
performed using the Rockhopper program, aligning the reads to the NCBI genome sequence of
N. gonorrhoeae strain FA1090 and then reporting the RNA-seq data in reads per kilobase per million
(RPKM) (37). The cutoff for gene expression was set at an RPKM value of at least 10. A composite set of
RPKM values was derived from RNA-seq data from the six male urethral samples and another from the
three newly collected cervicovaginal samples added to the four reported earlier (in the Gene Expression
Omnibus database under GenBank accession no. GSE71151) (38). These are referred to as “in vivo”
RNA-seq data. Data from gonococcal strains isolated from each subject and cultured in vitro were also
obtained (referred to as “in vitro” data).
Statistical analysis was performed on pooled data from each category of specimens: in vivo urethral,
in vivo cervicovaginal lavage, and in vitro. Genes with 2-fold change in expression and a q value of
0.05 in each category were deemed as regulated. Gene assignments and categorization were per-
formed using the KEGG and NCBI RefSeq public databases. Functional enrichment ratios were deter-
mined by dividing the percentage of genes in a functional category for a particular set of genes (e.g.,
highly expressed genes or differentially regulated genes) by the percentage of genes in the same
category present in the gonococcal genome as a whole. This ratio was used to interpret enrichment of
a particular set of genes that possessed a speciﬁc function. Fisher’s exact test was used to assign a P value
to the enrichment. Principal-component analysis (PCA) (88) was performed in R using singular value
decomposition on the scaled and centered data set of RPKM values for all genes in each subject, and the
resulting data were visualized by sex on a colored plot.
Whole-genome sequencing and analysis. N. gonorrhoeae isolates were grown on GC agar plates
supplemented with 1% IsoVitaleX and 0.6% fetal bovine serum at 37°C and 5% CO2 for 16 to 18 h.
Genomic DNA was extracted from a 10-l inoculum of each bacterial culture using a 5Prime DNA
extraction kit (5Prime, San Francisco, CA), following the manufacturer’s recommendations with slight
modiﬁcations. Whole-genome sequencing (WGS) was conducted using a PacBio RSII platform (Paciﬁc
Biosciences, Menlo Park, CA) with P5-C3 chemistry. De novo genome assembly was conducted using the
hierarchical genome assembly process workﬂow (HGAP3; SMRTAnalysis 2.3.0), which included consensus
polishing using Quiver (89). Single-nucleotide polymorphisms (SNPs) across sequenced isolates were
called de novo-assembled contigs using kSNP3 without a reference strain (90). Concatenated SNPs were
used to construct phylogenetic trees using the approximate-maximum-likelihood-based approach; trees
were visualized in FigTree (http://tree.bio.ed.ac.uk/software/ﬁgtree/). Antibiotic resistance elements were
identiﬁed using the Comprehensive Antibiotic Resistance Database (91) and the PubMLST Neisseria
database (https://pubmlst.org/neisseria) (92).
Data availability. New RNA-seq data from this study have been deposited in the Gene Expression
Omnibus (GSE113290). Genomic data from isolates have been deposited into NCBI under project no.
PRJNA329501 (see Table S2 in the supplemental material).
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